Crossmark

Towards accurate screening and prevention for PTSD (2-ASAP): protocol of a longitudinal prospective cohort study

Published Online: 2024-10-15

Authors

Karchoud, Jeanet F.

Hoeboer, Chris M.

Piwanski, Greta

Haagsma, Juanita A.

Olff, Miranda

van de Schoot, Rens

van Zuiden, Mirjam
Funding

Funding for this research was provided by:

ZonMw (636340004, 636340004, 636340004, 636340004, 636340004, 636340004, 636340004)
License Information

Text and Data Mining valid from 2024-10-15

Version of Record valid from 2024-10-15
More Information

Article History

Received: 13 June 2024

Accepted: 23 September 2024

First Online: 15 October 2024

Declarations

:

: The 2-ASAP cohort study was approved by the Institutional Review Board of the Amsterdam University Medical Centers on April 25, 2022 (NL80296.018.22; 2022.0030). The study is conducted according to the principles of the Declaration of Helsinki (1964, last updated 2013) and the Medical Research Involving Human Subjects Act (WMO). All researchers are trained in good clinical practice. Participants are extensively informed about the study both through information letters and orally and provide written informed consent prior to inclusion into the study.

: Not applicable.

: The authors declare no competing interests.

Document is current